News & Updates

A meta-analysis presented at ADA 2026 supports the benefits of hyperbaric oxygen therapy (HBOT) for ulcer healing and reducing the risk of major amputation in individuals with diabetic foot ulcers (DFUs).

Subtle signs may point to an underlying blood disorder such as blood cancers, and early testing can make a critical difference.

A public awareness survey focused on adult respiratory health in Malaysia, Indonesia, Singapore and the Philippines has discovered at least one in three respondents are not managing their health as well as they should, even though over 70 percent aim to achieve good fitness and health.

ARACOG, a phase II randomized trial, reports a significantly greater decline in objectively assessed cognitive function for advanced prostate cancer patients treated with enzalutamide vs darolutamide over 24 weeks, according to data presented at ASCO 2026.

Chiauranib plus weekly paclitaxel significantly extends progression-free survival (PFS) in patients with platinum-resistant or -refractory ovarian cancer, including those previously treated with anti-angiogenic agents, according to the findings of the phase III CHIPRO trial presented at ASCO 2026.